Principal findings of systematic reviews for chronic treatment in childhood asthma

Journal of Asthma

Volumn 52, Issue 4, 2015, Pages 407-416

  Castro Rodriguez, Jose A ^a   Rodrigo, Gustavo J ^b   Rodriguez Martinez, Carlos E ^c,d,e  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b HOSPITAL CENTRAL DE LAS FUERZAS ARMADAS   (Uruguay)

^c UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^d UNIVERSIDAD EL BOSQUE   (Colombia)

^e HOSPITAL MILITAR CENTRAL   (Colombia)

Author keywords

Adolescent; AMSTAR; Children; Chronic asthma management; Meta analysis; Systematic review; Treatment

Indexed keywords

ALLERGEN; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CICLESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FENOTEROL; FLUORINATED HYDROCARBON; FLUTICASONE PROPIONATE; HYDROCORTISONE; IMMUNOGLOBULIN E ANTIBODY; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING BETA 2 AGONIST; NEDOCROMIL; SHORT ACTING BETA2 AGONIST; STEROID; UNCLASSIFIED DRUG; XANTHINE; ANTIASTHMATIC AGENT; BRONCHODILATING AGENT;

ASTHMA; CHILD; CLINICAL EFFECTIVENESS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRY POWDER INHALER; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMMUNOTHERAPY; LONG TERM CARE; LUNG FUNCTION; METERED DOSE INHALER; PEAK EXPIRATORY FLOW; PEAK FLOWMETER; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW (TOPIC); WHEEZING; ADOLESCENT; CHRONIC DISEASE; DRUG ADMINISTRATION; DRUG COMBINATION; INHALATIONAL DRUG ADMINISTRATION; PRESCHOOL CHILD;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; LEUKOTRIENE ANTAGONISTS;

EID: 84931051996     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2014.971968     Document Type: Review

References (47)

1. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 1997;126: 376-380.
2. From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA). 2014. Available at: http://www.ginasthma.org/. Accessed June 2014.
3. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma, 2007. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
4. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007;7:10.
5. McDonald N, Bara A, McKean MC. Anticholinergic therapy for chronic asthma in children over two years of age. Cochrane Database Syst Rev 2003;(3):CD003535.
6. Walters EH, Walters JA, Gibson PW. Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma. Cochrane Database Syst Rev 2002;(4):CD003901.
7. Castro-Rodriguez JA, Rodrigo GJ. Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis. Pediatrics 2009; 123:e519-e525.
8. Adams NP, Bestall JC, Malouf R, Lasserson TJ, Jones P. Beclomethasone versus placebo for chronic asthma. Cochrane Database Syst Rev 2005;(1):CD002738.
9. Adams NP, Bestall JC, Lasserson TJ, Jones P, Cates CJ. Fluticasone versus placebo for chronic asthma in adults and children. Cochrane Database Syst Rev 2008;(4):CD003135.
10. Adams NP, Lasserson TJ, Cates CJ, Jones P. Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children. Cochrane Database Syst Rev 2007;(4):CD002310.
11. Barnes NC, Hallett C, Harris TA. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less. Respir Med 1998; 92:95-104.
12. Lasserson TJ, Cates CJ, Lasserson EH, White J. Fluticasone versus 'extrafine' HFA-beclomethasone dipropionate for chronic asthma in adults and children. Cochrane Database Syst Rev 2006;(2):CD005309.
13. Manning P, Gibson PG, Lasserson TJ. Ciclesonide versus other inhaled steroids for chronic asthma in children and adults. Cochrane Database Syst Rev 2008;(2):CD007031.
14. Kramer S, Rottier BL, Scholten RJPM, Boluyt N. Ciclesonide versus other inhaled corticosteroids for chronic asthma in children. Cochrane Database Syst Rev 2013;(2):CD010352.
15. Zhang L, Axelsson I, Chung M, Lau J. Dose response of inhaled corticosteroids in children with persistent asthma: a systematic review. Pediatrics 2011;127:129-138.
16. Adams NP, Bestall JC, Jones P, Lasserson TJ, Griffiths B, Cates CJ. Fluticasone at different doses for chronic asthma in adults and children. Cochrane Database Syst Rev 2008;(4):CD003534.
17. Quon BS, FitzGerald JM, Lemière C, Shahidi N, Ducharme FM. Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children. Cochrane Database Syst Rev 2010;(12):CD007524.
18. Chauhan BF, Chartrand C, Ducharme FM. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults. Cochrane Database Syst Rev 2013;(2):CD009611.
19. Rodrigo GJ, Castro-Rodriguez JA. Daily vs. intermittent inhaled corticosteroids for recurrent wheezing and mild persistent asthma: a sistematic review with meta-analysis. Respir Med 2013;107: 1133-1140.
20. Masoli M, Weatherall M, Holt S, Beasley R. Budesonide once versus twice-daily administration: meta-analysis. Respirology 2004; 9:528-534.
21. Masoli M, Weatherall M, Beasley R. Fluticasone given once versus twice a day: meta-analysis. Respirology 2005;10:183-188.
22. Brocklebank D, Wright J, Cates C. Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma. BMJ 2001;323:896-900.
23. Rank MA, Hagan JB, Park MA, Podjasek JC, Samant SA, Volcheck GW, Erwin PJ, West CP. The risk of asthma exacerbation after stopping low-dose inhaled corticosteroids: a systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol 2013;131:724-729.
24. Vuillermin PJ, Robertson CF, South M. Parent-initiated oral corticosteroid therapy for intermittent wheezing illnesses in children: systematic review. J Paediatr Child Health 2007;43:438-442.
25. Chauhan BF, Ducharme FM. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database Syst Rev 2012;(5):CD002314.
26. Castro-Rodriguez JA, Rodrigo GJ. The role of inhaled corticosteroids and montelukast in children with mild-moderate asthma: results of a systematic review with meta-analysis. Arch Dis Child 2010;95:365-370.
27. van der Wouden JC, Uijen JHJM, Bernsen RMD, Tasche MJA, de Jongste JC, Ducharme FM. Inhaled sodium cromoglycate for asthma in children. Cochrane Database Syst Rev 2008;(4): CD002173.
28. Sridhar AV, McKean MC. Nedocromil sodium for chronic asthma in children. Cochrane Database Syst Rev 2006;(3):CD004108.
29. Guevara JP, Ducharme FM, Keren R, Nihtianova S, Zorc J. Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma. Cochrane Database Syst Rev 2006;(2):CD003558.
30. Seddon P, Bara A, Lasserson TJ, Ducharme FM. Oral xanthines as maintenance treatment for asthma in children. Cochrane Database Syst Rev 2006;(1):CD002885.
31. Ni Chroinin M, Greenstone I, Lasserson TJ, Ducharme FM. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children. Cochrane Database Syst Rev 2009;(4):CD005307.
32. Chauhan BF, Ducharme FM. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma. Cochrane Database Syst Rev 2014;(1):CD003137.
33. Chauhan BF, Ben Salah R, Ducharme FM. Addition of antileukotriene agents to inhaled corticosteroids in children with persistent asthma. Cochrane Database Syst Rev 2013;(10): CD009585.
34. Ni Chroinin M, Lasserson TJ, Greenstone I, Ducharme FM. Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children. Cochrane Database Syst Rev 2009(3);CD007949.
35. Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev 2010;(5):CD005535.
36. Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Cochrane Database Syst Rev 2010;(4):CD005533.
37. Castro-Rodriguez JA, Rodrigo GJ. A systematic review of longacting b2-agonists versus higher doses of inhaled corticosteroids in asthma. Pediatrics 2012;130:e650-e657.
38. Lasserson TJ, Cates CJ, Ferrara G, Casali L. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. Cochrane Database Syst Rev 2008;(3):CD004106.
39. Cates CJ, Lasserson TJ. Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children. Cochrane Database Syst Rev 2009;(1): CD007085.
40. Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH. Anti-IgE for chronic asthma in adults and children. Cochrane Database Syst Rev 2006;(2):CD003559.
41. Rodrigo G, Rodrigo GJ, Neffen H, Castro-Rodriguez JA. Efficacy and safety of subcutaneous omalizumab vs placebo as add-on therapy to corticosteroids for children and adults with asthma: a systematic review. Chest 2011;139:28-35.
42. Ross RN, Nelson HS, Finegold I. Effectiveness of specific immunotherapy in the treatment of asthma: a meta-analysis of prospective, randomized, double-blind, placebo-controlled studies. Clin Ther 2000;22:329-341.
43. Abramson MJ, Puy RM, Weiner JM. Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev 2010;(8): CD001186.
44. Cloutier MM, Schatz M, Castro M, Kelly HW, Mangione-Smith R, Sheller J, Sorkness C, et al. Asthma outcomes: composite score of asthma control. J Allergy Clin Immunol 2012;129:S24-S33.
45. Fuhlbrigge A, Peden D, Apter A, Boushey HA, Camargo CA Jr, Gern J, Heymann PW, et al. Asthma outcomes: exacerbations. J Allergy Clin Immunol 2012;129:S34-S48.
46. Tepper RS, Wise RS, Covar R, Irvin CG, Kercsmar CM, Kraft M, Liu MC, et al. Asthma outcomes: pulmonary physiology. J Allergy Clin Immunol 2012;129:S65-S87.
47. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]: The Cochrane Collaboration; 2011. Available from: www.cochranehandbook. org [last accessed 31 Mar 2014].